Cargando…

Drug-induced Hypersensitivity Syndrome by EGFR-TKI in a Patient with Lung Cancer

An 83-years-old woman diagnosed with advanced Epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma was administered afatinib as a first-line treatment. On Day 17, the patient presented with grade 3 diarrhea and a blood test analysis showed an increased inflammatory response. Afatinib t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oyama, Baku, Morikawa, Kei, Sakaguchi, Tadashi, Tsunoda, Akihito, Kida, Hirotaka, Inoue, Takeo, Mineshita, Masamichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925278/ https://www.ncbi.nlm.nih.gov/pubmed/33518612 http://dx.doi.org/10.2169/internalmedicine.4237-19

Ejemplares similares

Bronchial Occlusion with Endobronchial Watanabe Spigot for Hemoptysis in a Mechanically Ventilated Patient with Extracorporeal Circulation
por: Sakaguchi, Tadashi, et al.
Publicado: (2018)

Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs
por: Morikawa, Kei, et al.
Publicado: (2022)

Evaluation of Droplet Countermeasures by a Particle Visualization System in Simulated Bronchoscopy
por: Morikawa, Kei, et al.
Publicado: (2021)

A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
por: Tsunoda, Akihito, et al.
Publicado: (2019)

Drastic healing process after pembrolizumab monotherapy in a case of advanced squamous cell carcinoma with severe bronchial stenosis observed over a two‐year period using continuous bronchoscopy: A case report
por: Morikawa, Kei, et al.
Publicado: (2020)

Detection of a pinhole‐sized bronchoesophageal fistula under bronchoscopic autofluorescence imaging
por: Morikawa, Kei, et al.
Publicado: (2021)

Efficacy of combined transbronchial lung cryobiopsy and conventional forceps biopsy for lung malignancies: a prospective cohort study
por: Kinoshita, Kohei, et al.
Publicado: (2023)

EML4-ALK Gene Mutation Detected with New NGS Lung Cancer Panel CDx Using Sputum Cytology in a Case of Advanced NSCLC
por: Morikawa, Kei, et al.
Publicado: (2023)

A case of advanced adenocarcinoma genetically confirmed with EGFR/BRAF co-mutation in both primary and metastatic lesions
por: Morikawa, Kei, et al.
Publicado: (2021)

The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non‐small cell lung cancer
por: Sakaguchi, Tadashi, et al.
Publicado: (2020)

Assessment of chemotherapy regimens on radiation pneumonitis in patients with unresectable stage III non‐small‐cell lung cancer after definitive chemoradiotherapy
por: Sakaguchi, Tadashi, et al.
Publicado: (2021)

Left and Right Lung Asynchrony as a Physiological Indicator for Unilateral Bronchial Obstruction in Interventional Bronchoscopy
por: Mineshita, Masamichi, et al.
Publicado: (2014)

A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens
por: Morikawa, Kei, et al.
Publicado: (2022)

Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non‐small cell lung cancer
por: Kakinuma, Kazutaka, et al.
Publicado: (2017)

The Correlation between Lung Sound Distribution and Pulmonary Function in COPD Patients
por: Mineshita, Masamichi, et al.
Publicado: (2014)

Suitability of transbronchial brushing cytology specimens for next‐generation sequencing in peripheral lung cancer
por: Furuya, Naoki, et al.
Publicado: (2020)

Successful treatment with nivolumab in a patient with lung adenocarcinoma complicated by pulmonary aspergilloma
por: Furuya, Naoki, et al.
Publicado: (2020)

Untreated Squamous Cell Lung Carcinoma May Contribute to the Occurrence of Hemophagocytic Syndrome
por: Koda, Eriko, et al.
Publicado: (2021)

Switching from first or second generation EGFR-TKI to osimertinib in EGFR mutation-positive NSCLC
por: Imamura, Fumio, et al.
Publicado: (2020)

Synergistic interaction between sorafenib and gemcitabine in EGFR-TKI-sensitive and EGFR-TKI-resistant human lung cancer cell lines
por: LI, JING, et al.
Publicado: (2013)

The correlation of p22(phox) and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma
por: Kobayashi, Masayuki, et al.
Publicado: (2019)

Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
por: Xia, Guo-Hao, et al.
Publicado: (2014)

Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
por: Cao, Peijun, et al.
Publicado: (2022)

Successful use of linezolid for refractory Mycobacterium abcessus infection: A case report
por: Inoue, Teppei, et al.
Publicado: (2017)

Dupilumab in a patient with severe asthma and glucocorticoid hypersensitivity: a case report
por: Handa, Hiroshi, et al.
Publicado: (2023)

Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury
por: Ohmori, Tohru, et al.
Publicado: (2021)

The Significance of MMP-1 in EGFR-TKI–Resistant Lung Adenocarcinoma: Potential for Therapeutic Targeting
por: Saito, Ryoko, et al.
Publicado: (2018)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
por: Chung, Fu-Tsai, et al.
Publicado: (2015)

RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report
por: Morikawa, Kei, et al.
Publicado: (2022)

A retrospective study of the efficacy of combined EGFR‑TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR‑TKI monotherapy for PD‑L1‑positive EGFR‑mutant non‑small cell lung cancer: North Japan Lung Cancer Study Group 2202
por: Inomata, Minehiko, et al.
Publicado: (2023)

Low‑dose anlotinib combined with EGFR‑TKI can be used as an alternative for EGFR‑TKI‑resistant non‑small cell lung cancer in elderly patients
por: Chen, Yi, et al.
Publicado: (2023)

EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
por: Gu, Weiguang, et al.
Publicado: (2023)

Pre-treatment bronchoscopic evaluation in a case of relapsing polychondrits
por: Kumagai, Kosumi, et al.
Publicado: (2023)

Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas
por: Lee, Ting-Fang, et al.
Publicado: (2018)

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
por: Wang, Qiming, et al.
Publicado: (2019)

Emerging Role of Noncoding RNAs in EGFR TKI-Resistant Lung Cancer
por: Li, Jingwei, et al.
Publicado: (2022)

Intractable pneumothorax managed by talc pleurodesis and bronchial occlusion with spigots
por: Ishida, Atsuko, et al.
Publicado: (2015)

EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials
por: Wu, Jing-Xun, et al.
Publicado: (2018)

EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI
por: Jung, Minkyu, et al.
Publicado: (2012)

Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
por: Kim, Seo Yun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fg0ku4vcnnvl43o6fljen7bojo